This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Oxytocic Pharmaceuticals Market

Market Insights on Oxytocic Pharmaceuticals covering sales outlook, demand forecast & up-to-date key trends

Oxytocic Pharmaceuticals Market by Indication (Abortion Induced Incomplete, Inevitable Abortion, Post-partum Haemorrhage, Labour Induction, Labour Arrest), Route of administration (Intravenous Infusion/Injection, Intramuscular Injection), Source of Origin, End-User & Region - Forecast to 2021-2031

Oxytocic Pharmaceuticals Market Snapshot

The oxytocic pharmaceuticals market revenue will total US$ 98.60 Mn in 2021, according to Future Market Insights (FMI). Exhibiting a CAGR of 7.74% between 2021 and 31, the market is expected to reach US$ 207.80 Mn by 2031.

Growth predictions remain positive for Europe due to rapid advancements in maternity care, rising government initiatives and growing number of elective caesareans. Germany will hold highest share in the Europe market, accounting for 31% of oxytocic pharmaceuticals sales in the region.

Customize this Report

Let us know your requirement to get
100% FREE customization

Key Points Covered In Oxytocic pharmaceuticals Market Research

  • Market Estimates And Forecast 2021 - 2031
  • Key drivers and restraints impacting the  market growth
  • Segment wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand share and Market share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Oxytocic Pharmaceuticals Market And How to Navigate
  • Recommendations on Key Winning Strategies

Oxytocic Pharmaceuticals Market Future Outlook for 2021-2031 vs Historic Sales

Improvements in newer oxytocic pharmaceuticals through licensing agreements will drive sales of the market over the forecast period. Besides this, expanding usage of Antepartum oxytocin injection for improvement in uterine contractions will positively influence the demand outlook for oxytocic pharmaceuticals.

With competition expected to soar in the coming years, manufactures are focusing on adopting strategies such as new product innovations, agreements and expansions to enhance their product portfolio.

Oxytocic Pharmaceuticals Market Download Report Brochure

For instance, in 2020, Iconovo announced its new developmental agreement with Monash University for production of inhaled oxytocin ICOone. The agreement allows Monash a complete global right to employ ICOone with oxyyocin to inhibit postpartum haemorrhage in women giving birth. This development aids in enhancing Iconovo’s industrial experience and leverages to use its inhalation experience in the upcoming projects. 

Coupled with this, mergers and acquisitions remain a key strategy among market players. For instance, in 2020, Tonix Pharmaceuticals announced a licensing deal with Katana Pharmaceuticals for augmenting the use of its intranasal potentiated oxytocin drug to cure metabolic disorders such as obesity, diabetes and insulin resistance.

Post-partum Haemorrhage to Lead Oxytocic Pharmaceuticals Market

The post-partum haemorrhage segment was estimated to account for more than 75% market share of the global oxytocic pharmaceuticals market by the end of forecast period and is expected to gain more than 200 BPS in its market share by 2026. The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Labour Induction during Childbirth Is Likely To Boost Post-Partum Haemorrhage Pharmaceuticals

Increasing childbirth using labour induction proves to be driving factor for the post-partum haemorrhage condition. There are certain situations – for instance, pre-eclampsia – where continuing the pregnancy is dangerous to the mother, or there are instances where women are uncomfortable, sore and tired. In such cases, labour is induced for convenience rather than medical reasons. However, labour induction increases the chances of post-partum haemorrhage.

According to the World Health Organization, the rate of labour induction in developing countries is lower; but in developed countries, the rates are relatively high, which is creating a positive impact on the post-partum haemorrhage segment. Another factor which is likely to fuel the revenue growth of the post-partum haemorrhage segment is the increasing age of mothers. Older and heavier women and women who are smokers are more likely to bleed heavily after delivery.

The ratio of getting pregnant after a certain age in life has increased in almost all the regions across the globe and this is creating robust development in the global oxytocic pharmaceuticals market, and specifically in the post-partum haemorrhage segment.

Demand in Africa Likely to Increase

The post-partum haemorrhage segment is the most attractive segment by indication in the North America oxytocic pharmaceuticals market, with a market attractiveness index of 3.9 estimated during the forecast period. In the Latin America region, the post-partum haemorrhage segment is estimated to reach a market attractiveness index of 3.7 due to increasing adolescent pregnancies. A majority of these pregnancies occur in Brazil in Latin America.

An increase in labour induction procedures in the region is responsible for positioning post-partum haemorrhage as the most attractive indication segment. The MEA region represents a higher prevalence of post-partum haemorrhage among all the regions owing to lack of proper nutrition to pregnant women. Africa’s contribution to the prevalence of post-partum haemorrhage in the MEA region is on the higher end, owing to a lack of healthcare infrastructure and awareness regarding pregnancy related aspects among African women.

Prevalence of post-partum haemorrhage is as high as 25.7% in African countries and 8.5% in Asian countries. In China, the post-partum haemorrhage segment is anticipated to record a market attractiveness index of 3.8 during the forecast period. A large pool of population and China’s altered single child policy to two children policy may likely increase the incidence of post-partum haemorrhage. 

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Opportunities in the Global Oxytocic Pharmaceuticals Market

Companies functioning in the global oxytocic pharmaceuticals market can reap larger market revenue from untapped markets in Asia and Africa where the prevalence of post-partum haemorrhage is on the higher side in comparison with other regions. Imparting awareness pertaining to pregnancy among the women in these regions can help create more market opportunities for existing as well as new entrants in the global oxytocic pharmaceuticals market.

The Report Segments the Market into Five Sections:

By Indication

  • Abortion Induced Incomplete
  • Inevitable Abortion
  • Post-partum Haemorrhage
  • Labour Induction
  • Labour Arrest

By Route of administration

  • Intravenous Infusion/Injection
  • Intramuscular Injection

By Source of Origin

  • Natural Oxytocin
  • Synthetic Oxytocin Derivative

By End-User

  • Hospitals
  • Maternity clinics

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan and China (APEJC)
  • Japan
  • China
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global oxytocic pharmaceuticals market will reach a valuation of US$ 98.60 Mn in 2021, rising at a CAGR of 7.74% between 2021 and 2031.

The oxytocic pharmaceuticals market exhibited growth at 3.60% CAGR between 2016 and 2020.

The combined market share of tier-1 players stood at 35-40% of the overall market.

The demand for oxytocic pharmaceuticals is expected to grow at 9% in North America between 2021 and 2031.

In 2021, Germany will account for approximately 31% share of oxytocic pharmaceuticals in the European region.

China, India, U.S., Japan, and GCC Countries are driving demand for oxytocic

Increasing labour induction procedures, growing prevalence of PPH andprequalification from WHO will drive the sales of Oxytocic Pharmaceuticals.

Highly fragmented market and increasing licensing activities are key trendsobserved in the market.

Japan accounts for 2.6% share in the global oxytocic pharmaceuticalsmarket.

Table of Content

1. Executive Summary

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3. Global Oxytocic Pharmaceuticals Market Analysis Scenario

3.1. Market Size (US$ Mn) and Forecast

3.1.1. Market Size and Y-o-Y Growth

3.1.2. Absolute $ Opportunity

4. Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5. Number of procedures by Indications per region (2015-2026)

4.6. Number of procedures by End User per region (2015-2026)

4.7. Number of cervical ripening procedures by region (2015)

4.8. Comparative drugs list other than Oxytocin

5. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Indication 

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Indication Type

5.3. Y-o-Y Growth Projections By Indication Type

5.4. Market Value Forecast By Indication, 2016–2026

5.4.1. Abortion Induced Incomplete

5.4.2. Inevitable Abortion

5.4.3. Postpartum Hemorrhage

5.4.4. Labor Induction

5.4.5. Labor Arrest

5.5. Market Attractiveness By Indication 

6. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By End User 

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By End User 

6.3. Y-o-Y Growth Projections By End User 

6.4. Market Value Forecast By End User, 2016–2026

6.4.1. Hospitals

6.4.2. Maternity Clinics

6.5. Market Attractiveness By End User 

7. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Route of Administration 

7.1. Introduction

7.2. Basis Point Share (BPS) Analysis By Route of Administration 

7.3. Y-o-Y Growth Projections By Route of Administration 

7.4. Market Value Forecast By Route of Administration, 2016–2026

7.4.1. Intravenous Infusion/Injection

7.4.2. Intramuscular Injection

7.5. Market Attractiveness By Route of Administration 

8. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Source of Origin 

8.1. Introduction

8.2. Basis Point Share (BPS) Analysis By Source of Origin 

8.3. Y-o-Y Growth Projections By Source of Origin 

8.4. Market Value Forecast By Source of Origin, 2016–2026

8.4.1. Synthetic Oxytocin Derivative

8.4.2. Natural Oxytocin (Animal Pituitary Extract)

8.5. Market Attractiveness By Source of Origin 

9. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Region

9.1. Basis Point Share (BPS) Analysis By Region

9.2. Y-o-Y Growth Projections By Region

9.3. Market Value Forecast By Region

9.3.1. North America 

9.3.2. Latin America 

9.3.3. Western Europe 

9.3.4. Eastern Europe 

9.3.5. China

9.3.6. Japan 

9.3.7. APEJC

9.3.8. MEA 

9.4. Market Attractiveness By Region

10. North America Oxytocic Pharmaceuticals Market Analysis and Forecast

10.1.Introduction

10.1.1. Basis Point Share (BPS) Analysis By Country

10.1.2. Y-o-Y Growth Projections By Country

10.2.Market Value Forecast By Indication, 2016–2026

10.2.1. Abortion Induced Incomplete

10.2.2. Inevitable Abortion

10.2.3. Postpartum Hemorrhage

10.2.4. Labor Induction

10.2.5. Labor Arrest

10.3.Market Value Forecast By End User, 2016–2026

10.3.1. Hospitals

10.3.2. Maternity Clinics

10.4.Market Value Forecast By Route of Administration, 2016–2026

10.4.1. Intravenous Infusion/Injection

10.4.2. Intramuscular Injection

10.5.Market Value Forecast By Source of Origin, 2016–2026

10.5.1. Synthetic Oxytocin Derivative

10.5.2. Natural Oxytocin (Animal Pituitary Extract)

10.6.Market Value Forecast By Country, 2016–2026

10.6.1. US

10.6.2. Canada

10.7.Market Attractiveness Analysis 

10.7.1. By Indication 

10.7.2. By End User 

10.7.3. By Route of Administration 

10.7.4. By Source of Origin 

10.7.5. By Country

10.8. Prominent Trends 

11. Latin America Oxytocic Pharmaceuticals Market Analysis and Forecast

11.1.Introduction

11.1.1. Basis Point Share (BPS) Analysis By Country

11.1.2. Y-o-Y Growth Projections By Country

11.2.Market Value Forecast By Indication, 2016–2026

11.2.1. Abortion Induced Incomplete

11.2.2. Inevitable Abortion

11.2.3. Postpartum Hemorrhage

11.2.4. Labor Induction

11.2.5. Labor Arrest

11.3.Market Value Forecast By End User, 2016–2026

11.3.1. Hospitals

11.3.2. Maternity Clinics

11.4.Market Value Forecast By Route of Administration, 2016–2026

11.4.1. Intravenous Infusion/Injection

11.4.2. Intramuscular Injection

11.5.Market Value Forecast By Source of Origin, 2016–2026

11.5.1. Synthetic Oxytocin Derivative

11.5.2. Natural Oxytocin (Animal Pituitary Extract)

11.6.Market Value Forecast By Country, 2016–2026

11.6.1. Brazil

11.6.2. Mexico

11.6.3. Rest of Latin America

11.7.Market Attractiveness Analysis 

11.7.1. By Indication 

11.7.2. By End User 

11.7.3. By Route of Administration 

11.7.4. By Source of Origin 

11.7.5. By Country

11.8. Prominent Trends 

12. Western Europe Oxytocic Pharmaceuticals Market Analysis and Forecast

12.1.Introduction

12.1.1. Basis Point Share (BPS) Analysis By Country

12.1.2. Y-o-Y Growth Projections By Country

12.2.Market Value Forecast By Indication, 2016–2026

12.2.1. Abortion Induced Incomplete

12.2.2. Inevitable Abortion

12.2.3. Postpartum Hemorrhage

12.2.4. Labor Induction

12.2.5. Labor Arrest

12.3.Market Value Forecast By End User, 2016–2026

12.3.1. Hospitals

12.3.2. Maternity Clinics

12.4.Market Value Forecast By Route of Administration, 2016–2026

12.4.1. Intravenous Infusion/Injection

12.4.2. Intramuscular Injection

12.5.Market Value Forecast By Source of Origin, 2016–2026

12.5.1. Synthetic Oxytocin Derivative

12.5.2. Natural Oxytocin (Animal Pituitary Extract)

12.6.Market Value Forecast By Country, 2016–2026

12.6.1. UK

12.6.2. France

12.6.3. Germany

12.6.4. Italy

12.6.5. Spain

12.6.6. Benelux

12.6.7. Rest of Western Europe

12.7.Market Attractiveness Analysis 

12.7.1. By Indication 

12.7.2. By End User 

12.7.3. By Route of Administration 

12.7.4. By Source of Origin 

12.7.5. By Country

12.8. Prominent Trends 

13. Eastern Europe Oxytocic Pharmaceuticals Market Analysis and Forecast

13.1.Introduction

13.1.1. Basis Point Share (BPS) Analysis By Country

13.1.2. Y-o-Y Growth Projections By Country

13.2.Market Value Forecast By Indication, 2016–2026

13.2.1. Abortion Induced Incomplete

13.2.2. Inevitable Abortion

13.2.3. Postpartum Hemorrhage

13.2.4. Labor Induction

13.2.5. Labor Arrest

13.3.Market Value Forecast By End User, 2016–2026

13.3.1. Hospitals

13.3.2. Maternity Clinics

13.4.Market Value Forecast By Route of Administration, 2016–2026

13.4.1. Intravenous Infusion/Injection

13.4.2. Intramuscular Injection

13.5.Market Value Forecast By Source of Origin, 2016–2026

13.5.1. Synthetic Oxytocin Derivative

13.5.2. Natural Oxytocin (Animal Pituitary Extract)

13.6.Market Value Forecast By Country, 2016–2026

13.6.1. Russia

13.6.2. Poland

13.6.3. Rest of Eastern Europe

13.7.Market Attractiveness Analysis 

13.7.1. By Indication 

13.7.2. By End User 

13.7.3. By Route of Administration 

13.7.4. By Source of Origin 

13.7.5. By Country

13.8. Prominent Trends 

14. APEJC Oxytocic Pharmaceuticals Market Analysis and Forecast

14.1.Introduction

14.1.1. Basis Point Share (BPS) Analysis By Country

14.1.2. Y-o-Y Growth Projections By Country

14.2.Market Value Forecast By Indication, 2016–2026

14.2.1. Abortion Induced Incomplete

14.2.2. Inevitable Abortion

14.2.3. Postpartum Hemorrhage

14.2.4. Labor Induction

14.2.5. Labor Arrest

14.3.Market Value Forecast By End User, 2016–2026

14.3.1. Hospitals

14.3.2. Maternity Clinics

14.4.Market Value Forecast By Route of Administration, 2016–2026

14.4.1. Intravenous Infusion/Injection

14.4.2. Intramuscular Injection

14.5.Market Value Forecast By Source of Origin, 2016–2026

14.5.1. Synthetic Oxytocin Derivative

14.5.2. Natural Oxytocin (Animal Pituitary Extract)

14.6.Market Value Forecast By Country, 2016–2026

14.6.1. India

14.6.2. Australia & New Zealand

14.6.3. ASEAN

14.6.4. Rest of APEJC

14.7.Market Attractiveness Analysis 

14.7.1. By Indication 

14.7.2. By End User 

14.7.3. By Route of Administration 

14.7.4. By Source of Origin 

14.7.5. By Country

14.8. Prominent Trends 

15. Japan Oxytocic Pharmaceuticals Market Analysis and Forecast

15.1.Introduction

15.1.1. Basis Point Share (BPS) Analysis By Country

15.1.2. Y-o-Y Growth Projections By Country

15.2.Market Value Forecast By Indication, 2016–2026

15.2.1. Abortion Induced Incomplete

15.2.2. Inevitable Abortion

15.2.3. Postpartum Hemorrhage

15.2.4. Labor Induction

15.2.5. Labor Arrest

15.3.Market Value Forecast By End User, 2016–2026

15.3.1. Hospitals

15.3.2. Maternity Clinics

15.4.Market Value Forecast By Route of Administration, 2016–2026

15.4.1. Intravenous Infusion/Injection

15.4.2. Intramuscular Injection

15.5.Market Value Forecast By Source of Origin, 2016–2026

15.5.1. Synthetic Oxytocin Derivative

15.5.2. Natural Oxytocin (Animal Pituitary Extract)

15.6.Market Attractiveness Analysis 

15.6.1. By Indication 

15.6.2. By End User 

15.6.3. By Route of Administration 

15.6.4. By Source of Origin 

15.7. Prominent Trends 

16. MEA Oxytocic Pharmaceuticals Market Analysis and Forecast

16.1.Introduction

16.1.1. Basis Point Share (BPS) Analysis By Country

16.1.2. Y-o-Y Growth Projections By Country

16.2.Market Value Forecast By Indication, 2016–2026

16.2.1. Abortion Induced Incomplete

16.2.2. Inevitable Abortion

16.2.3. Postpartum Hemorrhage

16.2.4. Labor Induction

16.2.5. Labor Arrest

16.3.Market Value Forecast By End User, 2016–2026

16.3.1. Hospitals

16.3.2. Maternity Clinics

16.4.Market Value Forecast By Route of Administration, 2016–2026

16.4.1. Intravenous Infusion/Injection

16.4.2. Intramuscular Injection

16.5.Market Value Forecast By Source of Origin, 2016–2026

16.5.1. Synthetic Oxytocin Derivative

16.5.2. Natural Oxytocin (Animal Pituitary Extract)

16.6.Market Value Forecast By Country, 2016–2026

16.6.1. GCC Countries

16.6.2. South Africa

16.6.3. Rest of MEA

16.7.Market Attractiveness Analysis 

16.7.1. By Indication 

16.7.2. By End User 

16.7.3. By Route of Administration 

16.7.4. By Source of Origin 

16.7.5. By Country

16.8. Prominent Trends 

17. China Oxytocic Pharmaceuticals Market Analysis and Forecast

17.1.Introduction

17.1.1. Basis Point Share (BPS) Analysis By Country

17.1.2. Y-o-Y Growth Projections By Country

17.2.Market Value Forecast By Indication, 2016–2026

17.2.1. Abortion Induced Incomplete

17.2.2. Inevitable Abortion

17.2.3. Postpartum Hemorrhage

17.2.4. Labor Induction

17.2.5. Labor Arrest

17.3.Market Value Forecast By End User, 2016–2026

17.3.1. Hospitals

17.3.2. Maternity Clinics

17.4.Market Value Forecast By Route of Administration, 2016–2026

17.4.1. Intravenous Infusion/Injection

17.4.2. Intramuscular Injection

17.5.Market Value Forecast By Source of Origin, 2016–2026

17.5.1. Synthetic Oxytocin Derivative

17.5.2. Natural Oxytocin (Animal Pituitary Extract)

17.6.Market Attractiveness Analysis 

17.6.1. By Indication 

17.6.2. By End User 

17.6.3. By Route of Administration 

17.6.4. By Source of Origin 

17.7. Prominent Trends 

18. Competition Landscape

18.1. Competition Dashboard

18.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

18.2.1. Fresenius Kaci AG

18.2.2. Biofutura SpA 

18.2.3. Baxter Healthcare Corporation 

18.2.4. Pfizer Inc. 

18.2.5. Ferring B.V. 

18.2.6. Novartis AG 

18.2.7. Teva Pharmaceutical Industries Ltd.

19. Assumptions and Acronyms Used

20. Research Methodology

 

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 2: Global Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 3: North America Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 4: North America Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 5: Latin America Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 6: Latin America Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 7: Western Europe Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 8: Western Europe Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 9: Eastern Europe Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 10: Eastern Europe Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 11: China Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 12: China Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 13: Japan Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 14: Japan Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 15: APEJC Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 16: APEJC Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 17: MEA Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 18: MEA Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 19: Global Cervical Ripening Procedures Market Volume (In Thousands) Analysis by Region, 2015

Table 20: Comparative drugs for controlling PPH conditions

Table 21: Comparative drugs for controlling PPH conditions

Table 22: Comparative drugs for controlling PPH conditions

Table 23: Comparative drugs for controlling PPH conditions

Table 24: Comparative drugs for controlling PPH conditions

Table 25: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2016 – 2026

Table 26: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2016 – 2026

Table 27: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 28: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 29: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Region, 2015–2026

Table 30: North America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 31: North America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 32: North America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 33: North America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 34: North America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 35: Latin America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 36: Latin America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 37: Latin America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 38: Latin America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 39: Latin America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 40: Western Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 41: Western Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 42: Western Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 43: Western Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 44: Western Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 45: Eastern Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 46: Eastern Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 47: Eastern Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 48: Eastern Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 49: Eastern Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 50: China Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 51: China Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 52: China Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 53: China Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 54: Japan Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 55: Japan Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 56: Japan Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 57: Japan Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 58: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 59: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 60: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 61: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 62: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 63: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 64: MEA Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 65: MEA Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 66: MEA Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 67: MEA Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 68: MEA Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Oxytocic Pharmaceuticals Market Value Share By, Indication, 2016

Figure 02: Global Oxytocic Pharmaceuticals Market Value Share By, Source of Origin, 2016

Figure 03: Global Oxytocic Pharmaceuticals Market Value Share By, Route of Administration, 2016

Figure 04: Global Oxytocic Pharmaceuticals Market Value Share By, Region, 2016

Figure 05: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Forecast, 2015–2026 

Figure 06: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity, 2015–2026 

Figure 07: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth, 2015–2026 

Figure 08: Global Oxytocic Pharmaceuticals Market Share Analysis (%) By Indication, 2016 - 2026

Figure 09: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Indication, 2016–2026 

Figure 10: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by abortion induced incomplete Segment, 2016 – 2026

Figure 11: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by inevitable abortion Segment, 2015 – 2026

Figure 12: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by post-partum hemorrhage Segment, 2015 – 2026

Figure 13: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by labor induction Segment, 2015 – 2026

Figure 14: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by labor arrest Segment, 2015 – 2026

Figure 15: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by labor arrest Segment, 2015 – 2026

Figure 16: Global Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016–2026 

Figure 17: Global Oxytocic Pharmaceuticals Market Share Analysis (%) By Route of Administration, 2016- 2026

Figure 18: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Route of Administration, 2016–2026 

Figure 19: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Intramuscular

Figure 20: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Intravenous Injection/Infusion Segment, 2015 – 2026

Figure 21: Global Oxytocic Pharmaceuticals Market Share Analysis (%) By Source of Origin, 2016- 2026

Figure 22: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Source of Origin, 2016–2026 

Figure 23: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Synthetic Oxytocin, 2015 – 2026

Figure 24: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Natural Oxytocin Segment, 2015 – 2026

Figure 25: Global Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016–2026 

Figure 26: Global Oxytocic Pharmaceuticals Market Share Analysis (%) By End User, 2016, 2026

Figure 27: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By End User, 2015–2026 

Figure 28: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Hospitals Segment, 2015 – 2026

Figure 29: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Maternity Centers Segment, 2015 – 2026

Figure 30: Global Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016–2026 

Figure 31: Global Oxytocic Pharmaceuticals Market Share Analysis (%) By Region, 2016, 2026

Figure 32: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Region, 2015–2026 

Figure 33: North America Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 34: Latin America Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 35: Western Europe Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 36: Eastern Europe Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 37: APEJC Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 38: Japan Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 39: MEA Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 40: China Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 41: Global Oxytocic Pharmaceuticals Market Attractiveness Analysis by Region, 2016–2026 

Figure 42: North America Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 43: North America Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 44: The U.S. Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 45: Canada Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 46: North America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 47: North America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 48: North America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 49: North America Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 50: Latin America Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 51: Latin America Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 52: The Brazil Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 53: Mexico Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 54: The Rest of Latin America Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 55: Latin America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 56: Latin America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 57: Latin America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 58: Latin America Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 59: Western Europe Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 60: Western Europe Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 61: Germany Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 62: France Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 63: Italy Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 64: Spain Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 65: U.K. Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 66: BENELUX Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 67: The Rest of Western Europe Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 68: Western Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 69: Western Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 70: Western Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 71: Western Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 72: Eastern Europe Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 73: Eastern Europe Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 74: Russia Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 75: Poland Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 76: The Rest of Eastern Europe Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 77: Eastern Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 78: Eastern Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 79: Eastern Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 80: Eastern Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 81: China Oxytocic Pharmaceuticals Market Attractiveness Analysis by Route of Administration, 2016 – 2026 

Figure 82: China Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 83: China Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 84: China Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 85: Japan Oxytocic Pharmaceuticals Market Attractiveness Analysis by Route of Administration, 2016 – 2026 

Figure 86: Japan Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 87: Japan Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 88: Japan Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 89: APEJC Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 90: APEJC Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 91: India Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 92: ASEAN Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 93: Australia & New Zealand Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 94: Rest of APEJC Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 95: APEJC Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 96: APEJC Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 97: APEJC Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 98: APEJC Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 99: MEA Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 100: MEA Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 101: GCC Countries Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 102: South Africa Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 103: The Rest of MEA Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 104: MEA Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 105: MEA Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 106: MEA Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 107: MEA Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Pharmaceutical Lipids Market

Published : April 2021

Healthcare

Pharmaceutical Incubators Market

Published : June 2018

Healthcare

Topical Antibiotic Pharmaceuticals Market

Published : April 2016

Healthcare

Pharmaceuticals Excipients Market

Published : March 2022

Google translate

Oxytocic Pharmaceuticals Market